AstraZeneca PLC
AstraZeneca PLC (AZN.L) Stock Competitors & Peer Comparison
See (AZN.L) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AZN.L | £11,086.00 | +0.00% | 177.4B | 28.90 | £3.96 | +1.89% |
| 0QCV.L | £146.95 | +0.00% | 221B | 21.08 | £6.97 | +4.40% |
| 0QAH.L | £80.07 | -0.01% | 206.1B | 11.93 | £6.88 | +3.99% |
| 0QQ6.L | £258.80 | +0.00% | 200.5B | 16.16 | £16.20 | +3.94% |
| 0R1F.L | £72.70 | +0.00% | 118.7B | 25.75 | £2.82 | +3.38% |
| GSK.L | £1,404.50 | +0.00% | 57.9B | 17.29 | £0.83 | +4.11% |
| DPH.L | £3,866.00 | +0.05% | 4.4B | -154.64 | -£0.25 | N/A |
| VEC.L | £164.80 | +0.00% | 0 | 0.08 | £20.10 | N/A |
Stock Comparison
AZN.L vs 0QCV.L Comparison August 2025
AZN.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AZN.L stands at 177.4B. In comparison, 0QCV.L has a market cap of 221B. Regarding current trading prices, AZN.L is priced at £11,086.00, while 0QCV.L trades at £146.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AZN.L currently has a P/E ratio of 28.90, whereas 0QCV.L's P/E ratio is 21.08. In terms of profitability, AZN.L's ROE is +0.20%, compared to 0QCV.L's ROE of +0.34%. Regarding short-term risk, AZN.L is less volatile compared to 0QCV.L. This indicates potentially lower risk in terms of short-term price fluctuations for AZN.L.Check 0QCV.L's competition here